Structure

Physi-Chem Properties

Molecular Weight:  426.15
Volume:  403.527
LogP:  -0.279
LogD:  -0.446
LogS:  -2.263
# Rotatable Bonds:  6
TPSA:  170.05
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  3
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.303
Synthetic Accessibility Score:  4.136
Fsp3:  0.55
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.996
MDCK Permeability:  6.841393042122945e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.986
Human Intestinal Absorption (HIA):  0.66
20% Bioavailability (F20%):  0.07
30% Bioavailability (F30%):  0.989

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.209
Plasma Protein Binding (PPB):  52.23517990112305%
Volume Distribution (VD):  0.423
Pgp-substrate:  27.805635452270508%

ADMET: Metabolism

CYP1A2-inhibitor:  0.086
CYP1A2-substrate:  0.049
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.097
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.216
CYP2D6-inhibitor:  0.028
CYP2D6-substrate:  0.186
CYP3A4-inhibitor:  0.007
CYP3A4-substrate:  0.038

ADMET: Excretion

Clearance (CL):  1.902
Half-life (T1/2):  0.482

ADMET: Toxicity

hERG Blockers:  0.083
Human Hepatotoxicity (H-HT):  0.274
Drug-inuced Liver Injury (DILI):  0.474
AMES Toxicity:  0.087
Rat Oral Acute Toxicity:  0.054
Maximum Recommended Daily Dose:  0.547
Skin Sensitization:  0.092
Carcinogencity:  0.174
Eye Corrosion:  0.003
Eye Irritation:  0.019
Respiratory Toxicity:  0.01

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC85624

Natural Product ID:  NPC85624
Common Name*:   Sid85149094
IUPAC Name:   6-[(2R)-2,3-dihydroxy-3-methylbutyl]-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
Synonyms:  
Standard InCHIKey:  DMCVVAVPFHUPNH-UPPPXSOGSA-N
Standard InCHI:  InChI=1S/C20H26O10/c1-20(2,27)14(22)6-10-5-9-3-4-15(23)28-11(9)7-12(10)29-19-18(26)17(25)16(24)13(8-21)30-19/h3-5,7,13-14,16-19,21-22,24-27H,6,8H2,1-2H3/t13-,14-,16-,17+,18-,19-/m1/s1
SMILES:  CC(C)([C@@H](Cc1cc2ccc(=O)oc2cc1O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1159420
PubChem CID:   44144279
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000145] Coumarins and derivatives
        • [CHEMONTID:0001743] Coumarin glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota roots Miyazaki prefecture, Japan n.a. PMID[9873511]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT10 Individual Protein Geminin Homo sapiens Potency n.a. 5.8 nM PMID[550693]
NPT29 Organism Rattus norvegicus Rattus norvegicus IC50 > 100000.0 nM PMID[550692]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 5.8 % PMID[550692]
NPT32 Organism Mus musculus Mus musculus IC50 > 100000.0 nM PMID[550692]
NPT32 Organism Mus musculus Mus musculus Inhibition = 49.0 % PMID[550692]
NPT8 Individual Protein DNA polymerase iota Homo sapiens Potency n.a. 7079.5 nM PMID[550693]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC85624 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9856 High Similarity NPC296377
0.9856 High Similarity NPC471764
0.9856 High Similarity NPC87950
0.9786 High Similarity NPC169510
0.9493 High Similarity NPC312881
0.9489 High Similarity NPC232246
0.9489 High Similarity NPC153818
0.9424 High Similarity NPC215512
0.9424 High Similarity NPC195357
0.9424 High Similarity NPC476442
0.9424 High Similarity NPC152771
0.9424 High Similarity NPC287286
0.942 High Similarity NPC279573
0.9416 High Similarity NPC103409
0.9416 High Similarity NPC224543
0.9416 High Similarity NPC188380
0.9416 High Similarity NPC78746
0.9379 High Similarity NPC470264
0.9348 High Similarity NPC294456
0.9348 High Similarity NPC212124
0.9348 High Similarity NPC155963
0.9348 High Similarity NPC184861
0.9348 High Similarity NPC225106
0.9348 High Similarity NPC281014
0.9343 High Similarity NPC472525
0.9296 High Similarity NPC469701
0.9296 High Similarity NPC226722
0.9281 High Similarity NPC151946
0.9281 High Similarity NPC211110
0.9275 High Similarity NPC38099
0.9275 High Similarity NPC26954
0.927 High Similarity NPC180716
0.927 High Similarity NPC62366
0.927 High Similarity NPC224475
0.927 High Similarity NPC213173
0.9197 High Similarity NPC296624
0.9197 High Similarity NPC471910
0.9197 High Similarity NPC207002
0.9197 High Similarity NPC167111
0.9197 High Similarity NPC133956
0.9197 High Similarity NPC318400
0.913 High Similarity NPC326600
0.913 High Similarity NPC166672
0.913 High Similarity NPC204353
0.913 High Similarity NPC267412
0.913 High Similarity NPC74655
0.913 High Similarity NPC164269
0.913 High Similarity NPC260265
0.913 High Similarity NPC198381
0.913 High Similarity NPC100986
0.913 High Similarity NPC50896
0.913 High Similarity NPC287182
0.913 High Similarity NPC47163
0.913 High Similarity NPC127888
0.913 High Similarity NPC319859
0.913 High Similarity NPC195343
0.913 High Similarity NPC18804
0.913 High Similarity NPC84894
0.9103 High Similarity NPC96294
0.9103 High Similarity NPC93924
0.9091 High Similarity NPC471824
0.9065 High Similarity NPC471625
0.9065 High Similarity NPC471909
0.9065 High Similarity NPC281241
0.9065 High Similarity NPC33986
0.9065 High Similarity NPC86892
0.9065 High Similarity NPC472424
0.9058 High Similarity NPC31849
0.9058 High Similarity NPC469449
0.9051 High Similarity NPC29734
0.9034 High Similarity NPC52740
0.9 High Similarity NPC471630
0.9 High Similarity NPC160727
0.9 High Similarity NPC55615
0.9 High Similarity NPC283019
0.9 High Similarity NPC476455
0.9 High Similarity NPC177281
0.9 High Similarity NPC128529
0.9 High Similarity NPC149320
0.8993 High Similarity NPC253574
0.8993 High Similarity NPC98179
0.8986 High Similarity NPC53587
0.8986 High Similarity NPC215060
0.8986 High Similarity NPC169404
0.8986 High Similarity NPC476352
0.8986 High Similarity NPC176186
0.898 High Similarity NPC114740
0.898 High Similarity NPC107197
0.8978 High Similarity NPC113098
0.8966 High Similarity NPC107120
0.8966 High Similarity NPC74320
0.8926 High Similarity NPC469699
0.8926 High Similarity NPC150442
0.8919 High Similarity NPC213197
0.8913 High Similarity NPC272650
0.8913 High Similarity NPC267336
0.8905 High Similarity NPC295970
0.8904 High Similarity NPC41844
0.8904 High Similarity NPC469700
0.8865 High Similarity NPC166180
0.8857 High Similarity NPC55149
0.8857 High Similarity NPC307412
0.8849 High Similarity NPC14248
0.8849 High Similarity NPC194277
0.8832 High Similarity NPC185066
0.8794 High Similarity NPC185778
0.8794 High Similarity NPC469675
0.8786 High Similarity NPC7526
0.8786 High Similarity NPC222036
0.8784 High Similarity NPC212670
0.8784 High Similarity NPC313334
0.8784 High Similarity NPC206264
0.8768 High Similarity NPC168710
0.8733 High Similarity NPC302610
0.8725 High Similarity NPC100818
0.8725 High Similarity NPC103116
0.8707 High Similarity NPC205361
0.8705 High Similarity NPC474491
0.8705 High Similarity NPC80170
0.8699 High Similarity NPC476457
0.8699 High Similarity NPC471763
0.8696 High Similarity NPC146540
0.869 High Similarity NPC84207
0.869 High Similarity NPC145319
0.869 High Similarity NPC49542
0.869 High Similarity NPC128337
0.869 High Similarity NPC230718
0.869 High Similarity NPC5253
0.869 High Similarity NPC139976
0.8686 High Similarity NPC471826
0.8671 High Similarity NPC471069
0.8671 High Similarity NPC124149
0.8671 High Similarity NPC262328
0.8671 High Similarity NPC471068
0.8671 High Similarity NPC87777
0.8658 High Similarity NPC106138
0.8652 High Similarity NPC141822
0.8652 High Similarity NPC142563
0.8652 High Similarity NPC163557
0.8652 High Similarity NPC241165
0.8652 High Similarity NPC469965
0.8652 High Similarity NPC1220
0.8652 High Similarity NPC291551
0.8652 High Similarity NPC205797
0.8649 High Similarity NPC15577
0.8639 High Similarity NPC476450
0.8636 High Similarity NPC173726
0.8636 High Similarity NPC241600
0.8636 High Similarity NPC43761
0.863 High Similarity NPC183646
0.863 High Similarity NPC119640
0.863 High Similarity NPC116922
0.8627 High Similarity NPC17521
0.8627 High Similarity NPC284810
0.8623 High Similarity NPC224774
0.8623 High Similarity NPC121740
0.8623 High Similarity NPC258567
0.8623 High Similarity NPC473993
0.8621 High Similarity NPC279851
0.8621 High Similarity NPC300611
0.8621 High Similarity NPC108674
0.8621 High Similarity NPC472520
0.8621 High Similarity NPC210192
0.8611 High Similarity NPC278600
0.8611 High Similarity NPC35501
0.8611 High Similarity NPC471072
0.8611 High Similarity NPC144512
0.8611 High Similarity NPC37428
0.8611 High Similarity NPC137262
0.8611 High Similarity NPC47040
0.8611 High Similarity NPC471070
0.8611 High Similarity NPC471071
0.8601 High Similarity NPC283331
0.8592 High Similarity NPC131950
0.8591 High Similarity NPC476348
0.8591 High Similarity NPC187398
0.8581 High Similarity NPC474044
0.8581 High Similarity NPC199928
0.8571 High Similarity NPC292443
0.8571 High Similarity NPC177597
0.8571 High Similarity NPC225445
0.8562 High Similarity NPC470604
0.8562 High Similarity NPC470605
0.8562 High Similarity NPC472353
0.8562 High Similarity NPC470603
0.8561 High Similarity NPC199204
0.8561 High Similarity NPC469453
0.8552 High Similarity NPC210478
0.8542 High Similarity NPC131198
0.854 High Similarity NPC201667
0.854 High Similarity NPC111347
0.854 High Similarity NPC73413
0.8531 High Similarity NPC79957
0.8523 High Similarity NPC476347
0.8516 High Similarity NPC470607
0.8511 High Similarity NPC103799
0.8506 High Similarity NPC45165
0.8503 High Similarity NPC469367
0.8497 Intermediate Similarity NPC268950
0.8497 Intermediate Similarity NPC108706

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC85624 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8784 High Similarity NPD1653 Approved
0.8652 High Similarity NPD5123 Clinical (unspecified phase)
0.8652 High Similarity NPD5124 Phase 1
0.8493 Intermediate Similarity NPD1652 Phase 2
0.8333 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8188 Intermediate Similarity NPD1091 Approved
0.8098 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD6559 Discontinued
0.8058 Intermediate Similarity NPD422 Phase 1
0.8025 Intermediate Similarity NPD8455 Phase 2
0.8025 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD7075 Discontinued
0.7962 Intermediate Similarity NPD6801 Discontinued
0.7949 Intermediate Similarity NPD4380 Phase 2
0.7867 Intermediate Similarity NPD7266 Discontinued
0.7823 Intermediate Similarity NPD1613 Approved
0.7823 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD3818 Discontinued
0.7815 Intermediate Similarity NPD2424 Discontinued
0.7808 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD7097 Phase 1
0.7771 Intermediate Similarity NPD7054 Approved
0.7727 Intermediate Similarity NPD5058 Phase 3
0.7725 Intermediate Similarity NPD7472 Approved
0.7725 Intermediate Similarity NPD7074 Phase 3
0.7702 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7819 Suspended
0.7687 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD6797 Phase 2
0.7673 Intermediate Similarity NPD7411 Suspended
0.7671 Intermediate Similarity NPD4908 Phase 1
0.7665 Intermediate Similarity NPD5844 Phase 1
0.7647 Intermediate Similarity NPD6674 Discontinued
0.7643 Intermediate Similarity NPD5403 Approved
0.7633 Intermediate Similarity NPD7251 Discontinued
0.7628 Intermediate Similarity NPD5401 Approved
0.7625 Intermediate Similarity NPD37 Approved
0.7622 Intermediate Similarity NPD7199 Phase 2
0.7597 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD4967 Phase 2
0.7593 Intermediate Similarity NPD4965 Approved
0.7593 Intermediate Similarity NPD4966 Approved
0.7588 Intermediate Similarity NPD7808 Phase 3
0.7578 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD6799 Approved
0.7552 Intermediate Similarity NPD1610 Phase 2
0.7551 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD3817 Phase 2
0.7531 Intermediate Similarity NPD5402 Approved
0.7518 Intermediate Similarity NPD1548 Phase 1
0.7517 Intermediate Similarity NPD8651 Approved
0.7516 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3027 Phase 3
0.75 Intermediate Similarity NPD7228 Approved
0.75 Intermediate Similarity NPD6234 Discontinued
0.7486 Intermediate Similarity NPD7583 Approved
0.7484 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD4628 Phase 3
0.7484 Intermediate Similarity NPD3750 Approved
0.7483 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7467 Intermediate Similarity NPD4060 Phase 1
0.7453 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD2796 Approved
0.745 Intermediate Similarity NPD6798 Discontinued
0.745 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7446 Intermediate Similarity NPD7585 Approved
0.7434 Intermediate Similarity NPD4536 Approved
0.7434 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD4538 Approved
0.7432 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD2415 Discontinued
0.7419 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD1934 Approved
0.7405 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD6599 Discontinued
0.7386 Intermediate Similarity NPD7033 Discontinued
0.7386 Intermediate Similarity NPD3748 Approved
0.7383 Intermediate Similarity NPD4625 Phase 3
0.7378 Intermediate Similarity NPD7768 Phase 2
0.7355 Intermediate Similarity NPD1549 Phase 2
0.7347 Intermediate Similarity NPD2797 Approved
0.7345 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD8313 Approved
0.7341 Intermediate Similarity NPD8312 Approved
0.7338 Intermediate Similarity NPD7843 Approved
0.7333 Intermediate Similarity NPD1296 Phase 2
0.7329 Intermediate Similarity NPD4749 Approved
0.7326 Intermediate Similarity NPD7240 Approved
0.7317 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD920 Approved
0.7312 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD7157 Approved
0.7303 Intermediate Similarity NPD4340 Discontinued
0.7303 Intermediate Similarity NPD6355 Discontinued
0.7299 Intermediate Similarity NPD2684 Approved
0.729 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD5763 Approved
0.729 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD5762 Approved
0.7285 Intermediate Similarity NPD6233 Phase 2
0.7283 Intermediate Similarity NPD7549 Discontinued
0.7279 Intermediate Similarity NPD3225 Approved
0.7278 Intermediate Similarity NPD6166 Phase 2
0.7278 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6843 Phase 3
0.7273 Intermediate Similarity NPD5960 Phase 3
0.7273 Intermediate Similarity NPD5588 Approved
0.7273 Intermediate Similarity NPD6842 Approved
0.7273 Intermediate Similarity NPD6841 Approved
0.7267 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD3496 Discontinued
0.7226 Intermediate Similarity NPD1358 Approved
0.7226 Intermediate Similarity NPD290 Approved
0.7222 Intermediate Similarity NPD5691 Approved
0.7219 Intermediate Similarity NPD3268 Approved
0.7214 Intermediate Similarity NPD5535 Approved
0.7204 Intermediate Similarity NPD7584 Approved
0.7197 Intermediate Similarity NPD1243 Approved
0.7195 Intermediate Similarity NPD4433 Discontinued
0.7193 Intermediate Similarity NPD3751 Discontinued
0.7188 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD6005 Phase 3
0.7179 Intermediate Similarity NPD6004 Phase 3
0.7179 Intermediate Similarity NPD6002 Phase 3
0.7179 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD4626 Approved
0.717 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD1510 Phase 2
0.7161 Intermediate Similarity NPD4308 Phase 3
0.716 Intermediate Similarity NPD3787 Discontinued
0.7152 Intermediate Similarity NPD2801 Approved
0.7152 Intermediate Similarity NPD1465 Phase 2
0.7152 Intermediate Similarity NPD7095 Approved
0.7143 Intermediate Similarity NPD5494 Approved
0.7133 Intermediate Similarity NPD2861 Phase 2
0.7126 Intermediate Similarity NPD7685 Pre-registration
0.7125 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD4140 Approved
0.7117 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD7458 Discontinued
0.7115 Intermediate Similarity NPD2935 Discontinued
0.7115 Intermediate Similarity NPD1551 Phase 2
0.7105 Intermediate Similarity NPD2313 Discontinued
0.7101 Intermediate Similarity NPD8127 Discontinued
0.7097 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6832 Phase 2
0.7083 Intermediate Similarity NPD919 Approved
0.708 Intermediate Similarity NPD9697 Approved
0.7078 Intermediate Similarity NPD1933 Approved
0.7063 Intermediate Similarity NPD6667 Approved
0.7063 Intermediate Similarity NPD6666 Approved
0.7062 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6232 Discontinued
0.7055 Intermediate Similarity NPD5125 Phase 3
0.7055 Intermediate Similarity NPD5126 Approved
0.7051 Intermediate Similarity NPD2799 Discontinued
0.7044 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD3134 Approved
0.7025 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD3749 Approved
0.7019 Intermediate Similarity NPD7212 Phase 2
0.7019 Intermediate Similarity NPD7213 Phase 3
0.7019 Intermediate Similarity NPD1511 Approved
0.7013 Intermediate Similarity NPD4307 Phase 2
0.7012 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6190 Approved
0.7 Intermediate Similarity NPD3267 Approved
0.7 Intermediate Similarity NPD6959 Discontinued
0.7 Intermediate Similarity NPD3266 Approved
0.6993 Remote Similarity NPD7985 Registered
0.6975 Remote Similarity NPD2532 Approved
0.6975 Remote Similarity NPD2534 Approved
0.6975 Remote Similarity NPD2533 Approved
0.6975 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6975 Remote Similarity NPD7447 Phase 1
0.6964 Remote Similarity NPD3882 Suspended
0.6963 Remote Similarity NPD7783 Phase 2
0.6963 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6959 Remote Similarity NPD7229 Phase 3
0.6959 Remote Similarity NPD3705 Approved
0.6954 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6952 Remote Similarity NPD7435 Discontinued
0.6948 Remote Similarity NPD4062 Phase 3
0.6944 Remote Similarity NPD6671 Approved
0.6939 Remote Similarity NPD1778 Approved
0.6937 Remote Similarity NPD4535 Phase 3
0.6936 Remote Similarity NPD7473 Discontinued
0.6933 Remote Similarity NPD1512 Approved
0.6923 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6653 Approved
0.6913 Remote Similarity NPD9717 Approved
0.6909 Remote Similarity NPD3226 Approved
0.6908 Remote Similarity NPD3018 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data